Phase 1 Randomized, Placebo-Controlled, Partially Blinded, Single Ascending Dose Study on the Effects of Troriluzole on Corrected QT in Healthy Subjects
Latest Information Update: 23 Jan 2025
Price :
$35 *
At a glance
- Drugs Troriluzole (Primary) ; Moxifloxacin; Riluzole
- Indications Alzheimer's disease; Glioblastoma; Obsessive-compulsive disorders; Spinocerebellar degeneration
- Focus Adverse reactions
- 23 Jan 2025 New trial record